Role of Vascular Endothelial Growth Factor–A in Recurrent Respiratory Papillomatosis
Authors:
- Sara O. VargasSVSara O. Vargas
- Gerald B. HealyGHGerald B. Healy
- Judah FolkmanJFJudah Folkman
- Xiaolian TanXTXiaolian Tan
- Trevor J. McGillTMTrevor J. McGill
- 1 April 2005
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 114 (4) , 289-295
Abstract
Vascular endothelial growth factor–A (VEGF-A) is known to play an important role in the angiogenic response essential for tumor growth in a variety of human and experimental tumors. This study was designed to investigate whether VEGF-A may play a role in the pathogenesis of recurrent respiratory papillomatosis (RRP). A retrospective study with institutional review board approval was performed at a tertiary care medical center on 12 patients with a history of laryngeal RRP. Their ages at the time of initial diagnosis ranged from 19 to 96 months (mean, 56 months). All patients had involvement of right and left true vocal cords. All patients required multiple endoscopic procedures (range, 4 to 66; mean, 12). Normal pediatric larynx samples from 5 autopsy patients were used as controls. Formalin-fixed, paraffin-embedded sections of laryngeal squamous papillomas from the 12 patients with a diagnosis of RRP and the 5 control patients were examined by in situ hybridization for the presence of messenger RNA (mRNA) for VEGF-A and vascular endothelial growth factor receptor 1 (VEGFR-1) and vascular endothelial growth factor receptor 2 (VEGFR-2). The biopsy specimens were from the true vocal cord (N = 10) or subglottis (N = 2) in the patients with RRP and consisted of large sections of larynx including the true vocal cord in the control patients (N = 5). Strong expression of VEGF-A mRNA was noted in the squamous epithelium of papillomas of all 12 patients. Strong expression of VEGFR-1 and VEGFR-2 was noted in the endothelial cells of the underlying vessels in all 12 patients. Neither strong labeling of VEGF-A mRNA nor labeling of its receptors was noted in the control patients. We conclude that the angiogenic growth factor VEGF-A is strongly expressed in the epithelium of squamous papillomas in RRP. Also, VEGFR-1 and VEGFR-2 mRNAs are strongly expressed by underlying vascular endothelial cells, suggesting an important role in the pathogenesis of RRP.Keywords
This publication has 35 references indexed in Scilit:
- Recurrent Respiratory PapillomatosisThe Laryngoscope, 2001
- Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.Journal of Experimental Medicine, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Papillomaviruses in head and neck disease: Pathophysiology and possible regulationJournal of Cellular Biochemistry, 1993
- Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.Journal of Experimental Medicine, 1992
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989
- Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.Journal of Cell Biology, 1989
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Laryngeal papillomatosis: Clinical, histopathologic and molecular studiesThe Laryngoscope, 1987